Humanized mouse model for in vivo evaluation of bispecific antibody efficacy

被引：0
|
作者：
Yao, Li-Chin [1 ]
Keck, James G. [1 ]
Cai, Danying [1 ]
机构：
[1] Jackson Lab, Sacramento, CA USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1338
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Human stem cell humanized mouse model for in vivo evaluation of bispecific antibody efficacy and drug-induced cytokine release
    Yao, Li-Chin
    Cai, Danying
    Aliperta, Roberta
    Colthart, Allison
    Meier, Werner
    Cheng, Mingshan
    Keck, James G.
    CANCER RESEARCH, 2020, 80 (16)
  • [2] An in vivo PBMC humanized mouse model for determining checkpoint and bispecific antibody treatment related cytokine release syndrome
    Ye, Chunting
    Cheng, Mingshan
    Brehm, Michael
    Greiner, Dale
    Shultz, Leonard
    Keck, James
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [3] Simultaneous evaluation of treatment efficacy and toxicity for bispecific T-cell engager therapeutics in a humanized mouse model
    Yang, Jiwon
    Jiao, Jing
    Draheim, Kyle M.
    Yang, Guoxiang
    Yang, Hongyuan
    Yao, Li-Chin
    Shultz, Leonard D.
    Greiner, Dale L.
    Rajagopal, Deepa
    Vessillier, Sandrine
    Maier, Curtis C.
    Mohanan, Sunish
    Cai, Danying
    Cheng, Mingshan
    Brehm, Michael A.
    Keck, James G.
    FASEB JOURNAL, 2023, 37 (06):
  • [4] An in vivo humanized mouse model for determining donor-dependent cytokine release syndrome in response to checkpoint and bispecific antibody therapy
    Draheim, Kyle M.
    Yang, Jiwon
    Jiao, Jing
    Cheng, Mingshan
    Keck, James G.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [5] IN VIVO STUDIES OF IMMUNOMODULATORY A-CTLA-4 ANTIBODY IN A HUMANIZED MOUSE MODEL
    Reitinger, C.
    Nimmerjahn, F.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A22 - A22
  • [6] Preclinical evaluation of the efficacy of an antibody to human SIRPα for cancer immunotherapy in humanized mouse models
    Saito, Yasuyuki
    Iida-Norita, Rie
    Afroj, Tania
    Refaat, Alaa
    Hazama, Daisuke
    Komori, Satomi
    Ohata, Shinya
    Takai, Tomoko
    Oduori, Okechi S.
    Kotani, Takenori
    Funakoshi, Yohei
    Koma, Yu-Ichiro
    Murata, Yoji
    Yakushijin, Kimikazu
    Matsuoka, Hiroshi
    Minami, Hironobu
    Yokozaki, Hiroshi
    Manz, Markus G.
    Matozaki, Takashi
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [7] Humanized mouse model for in vivo antibody-dependent cell-mediated cytotoxicityevaluation
    Mirjolet, Jean-Francois
    Mignard, Caroline
    de Boisferon, Marc Hillairet
    Duchamp, Olivier
    Bichat, Francis
    Genne, Philippe
    CANCER RESEARCH, 2009, 69
  • [8] Efficacy evaluation of bispecific antibodies in humanized mice after B cell depletion
    Gan, Tian
    Li, Dirui
    Yang, Hao
    Ng, Gary
    Li, Yanan
    Lin, Qingcong
    CANCER RESEARCH, 2020, 80 (16)
  • [9] The efficacy of anti-PD-1 antibody for IVLBCL in humanized immune system mouse model
    Takai, Mika
    Shimada, Kazuyuki
    Kiyoi, Hitoshi
    CANCER SCIENCE, 2024, 115 : 1018 - 1018
  • [10] Development of a new tumor-bearing humanized mouse model to evaluate the efficacy and toxicity of bispecific T cell engagers
    Yang, Guoxiang
    Yao, Li-Chin
    Brehm, Michael A.
    Greiner, Dale L.
    Shultz, Leonard D.
    Cai, Danying
    Cheng, MIngshan
    Keck, James G.
    CANCER RESEARCH, 2022, 82 (12)
12345